Study guide
Health Promotion, Risk Reduction, and Epidemiology
OCN Oncology Certified Nurse Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: OCN Exam Orientation and Official Source Control
Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness
2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care
Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures
3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment
Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation
4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards
Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development
5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy
Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation
6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents
Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation
7 Chapter 7: Symptom Management and Supportive Care
Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination
8 Chapter 8: Oncologic Emergencies and Rapid Escalation
Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage
9 Chapter 9: Psychosocial Dimensions of Oncology Care
Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals
10 Chapter 10: Mixed OCN Case Labs
New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab
11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness
Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning
Health Promotion, Risk Reduction, and Epidemiology
Key Takeaways Explain This Topic AI
OCN practice links prevention counseling to individualized risk, readiness to change, and survivorship or treatment context.
Epidemiology lets nurses explain incidence, prevalence, mortality, and disparities, and why screening priorities differ by population.
Modifiable risk reduction includes tobacco cessation, vaccination, weight management, activity, alcohol reduction, UV protection, and occupational safety.
The 5 A's (Ask, Advise, Assess, Assist, Arrange) structure brief tobacco-cessation counseling within the oncology nurse role.
Prevention continues after diagnosis because second cancers, infection, deconditioning, and treatment complications remain relevant.
Last updated: June 2026
- Health Promotion, Risk Reduction, and Epidemiology
- OCN focus and exam context
Health promotion on the Oncology Certified Nurse (OCN) exam is not generic wellness advice. The exam, administered by the Oncology Nursing Certification Corporation (ONCC) , contains 165 multiple-choice items (145 scored, 20 unscored pretest) delivered in a 3-hour PSI session; passing requires a scaled score of 55 on a 25-to-75 scale. Prevention questions test the nurse's ability to connect epidemiologic risk, cancer biology, treatment status, and patient readiness into one practical plan. A newly diagnosed patient, a 10-year survivor, and a caregiver asking about family risk each need teaching, but the priority and language differ.
Assess baseline knowledge, health literacy, cultural beliefs, access, and competing stressors before teaching.
Epidemiology at the bedside
Epidemiology describes the distribution and determinants of cancer in populations. The four core measures appear repeatedly on the exam:
Measure Definition Nursing application
Incidence New cases per population per time Explain why age, sex, exposures, and inherited syndromes shift risk
Prevalence People alive with a cancer history at a point in time Drives survivorship, surveillance, and late-effect workload
Mortality Deaths per population per time Justifies prevention and early detection for poor-prognosis cancers
Survival Outcomes after diagnosis (e.g., 5-year relative survival) Frames realistic prognosis and goals discussions
In the United States, the three leading cancer killers are lung, colorectal, and pancreatic for combined sexes, while breast, prostate, lung, and colorectal lead in incidence. Lung cancer mortality remains high, so tobacco cessation is a priority even during treatment for an unrelated malignancy . Breast cancer prevalence is high because patients live many years post-diagnosis, generating ongoing surveillance and late-effect work.
Scenario-driven prevention priorities
The best OCN answer usually targets the risk that is both important and changeable. A 58-year-old on adjuvant chemotherapy who smokes should receive brief cessation counseling, dependence assessment, and referral to pharmacologic plus behavioral support. A melanoma survivor needs ultraviolet (UV) protection teaching and prompt evaluation of new pigmented lesions. A patient starting anti-CD20 therapy (e.g., rituximab) needs an immunization review before immunosuppression, because live vaccines become contraindicated.
The 5 A's for tobacco cessation
Tobacco causes roughly one-third of cancer deaths and worsens wound healing, infection, and treatment toxicity. ONS endorses the brief 5 A's model:
- Ask about current and past use at every visit
- Advise to quit with a clear, personalized, nonjudgmental message
- Assess readiness to quit (readiness-to-change stage)
- Assist with pharmacotherapy and counseling referral (quitline 1-800-QUIT-NOW)
- Arrange follow-up to reinforce and adjust the plan
Alcohol reduction matters for breast, liver, head and neck, esophageal, and colorectal cancers; even moderate intake raises breast cancer risk. Nutrition counseling should emphasize sustainable, plant-forward patterns with adequate protein during treatment; refer to an oncology dietitian for unintended weight loss, dysphagia, mucositis, or food insecurity. Obesity is itself an independent risk factor for at least 13 cancers, including endometrial, esophageal, kidney, pancreatic, and postmenopausal breast cancer, so weight management is framed as risk reduction, not appearance.
Physical activity counseling
Physical activity reduces cancer-related fatigue, supports function, and improves mood, but recommendations must account for anemia, bone metastases, neuropathy, fall risk, surgical restrictions, neutropenia, and cardiopulmonary status . General survivorship guidance favors gradual, individualized activity rather than a one-size prescription. A patient with lytic bone metastases needs activity that protects skeletal stability; a thrombocytopenic patient avoids contact activity with bleeding risk; a neutropenic patient avoids crowds and shared equipment until counts recover.
The nurse adapts the message to the patient's current treatment phase rather than repeating generic exercise advice.
Vaccination as cancer prevention
Vaccination is primary prevention. Human papillomavirus (HPV) vaccination prevents cervical, anal, oropharyngeal, vulvar, vaginal, and penile cancers. Hepatitis B vaccination lowers hepatocellular carcinoma risk. Inactivated influenza, COVID-19, pneumococcal, and other indicated vaccines protect immunocompromised patients, while live vaccines (MMR, varicella, live-attenuated influenza) are generally contraindicated during active immunosuppression and require provider timing.
Teaching without blame and when to escalate
Prevention must never imply the patient caused the disease. A therapeutic frame: "Some risks are inherited or environmental and some can be changed. Let's focus on what helps now." OCN scenarios often include patients who feel guilt about smoking, weight, sun exposure, or delayed screening; the therapeutic response validates the emotion, avoids judgment, and offers concrete support. Refer to genetic counseling for hereditary patterns: diagnosis at a young age, multiple primary cancers, rare tumors, or several affected relatives across generations.
Refer to social work when cost, food insecurity, housing, or unsafe occupational exposure (radon, asbestos, solvents, pesticides, shift work) blocks prevention. Refer to rehabilitation or exercise specialists when activity goals are limited by pain, weakness, lymphedema risk, or falls.
Occupational and environmental exposures belong in the assessment whenever history or community risk makes them relevant; the nurse asks about protective equipment, ventilation, and duration of exposure. The oncology nurse's role across all of these domains is consistent: assess baseline status and readiness, teach in plain language matched to literacy, coordinate the right referral, document the teaching and barriers, and arrange follow-up so the plan is acted on rather than forgotten.